Latest / Stock Movers / Genmab Gains, Sabadell Rises, Vend Tumbles
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios. Podcasts. Radio. News. The Stock Movers Report.
- 0:10Speaker 1: Your roundup of companies making moves in the stock market.
- 0:13Speaker 1: Harnessing the power of Bloomberg data.
- 0:16Speaker 2: Let's take a look at some stocks on the move
- 0:18Speaker 2: today in Europe. I'm Stephen Carroll with Anna Edwards and
- 0:20Speaker 2: we're joined by Bloomberg's breaking news editor Louise Moon.
- 0:23Speaker 1: Louise, good morning.
- 0:24Speaker 2: Let's start with biotechnology and the Danish firm Genmap. Their
- 0:28Speaker 2: shares are up sharply today. What's going on?
- 0:31Speaker 3: Indeed, yeah, up over about 8% in morning trading. It's
- 0:34Speaker 3: combination medicine with AbbVie, the US firm for lymphoma. Essentially,
- 0:41Speaker 3: they've had positive results from a trial there. So, it's
- 0:43Speaker 3: cutting the risk of disease progression or death by more
- 0:46Speaker 3: than 50%. So, good results there. Analysts are saying it's
- 0:49Speaker 3: well worth the wait. It's a significant win. It clears
- 0:53Speaker 3: the bar for success. And it also means that GEMAB
- 0:56Speaker 3: could potentially file with regulators earlier than expected. Shares have
- 1:01Speaker 3: been on a bit of a streak. They're up about 20%
- 1:04Speaker 3: over the past year and really having risen strongly since
- 1:07Speaker 3: about June. They've had quite a few bits of positive news,
- 1:10Speaker 3: some related to other tie-ups with AbbVie. They also had
- 1:14Speaker 3: separate positive trial data on Monday related to ovarian cancer. So,
- 1:18Speaker 3: there's been quite a host of positive news and this
- 1:20Speaker 3: is the latest in terms of good trial results. Next up,
- 1:24Speaker 3: let's go to Informa.
- 1:26Speaker 1: Shares rising today, Louise. Yeah.
- 1:28Speaker 3: So, Informa is the events firm here in London. So,
- 1:31Speaker 3: it specializes in putting on kind of trade shows. They
- 1:34Speaker 3: have bought Clarion, which is another events firm. They specialize
- 1:38Speaker 3: in exhibitions. So, slightly different area. But they bought it
- 1:41Speaker 3: from Blackstone for about £ 2. 24 billion. That's including debt. So,
- 1:45Speaker 3: they say that it will create one of the world's
- 1:47Speaker 3: largest business-to-business events operators. And notably, they're both U.K. companies,
- 1:52Speaker 3: which at the moment in the M & A world
- 1:54Speaker 3: is relatively rare. So, they expect to generate more than
- 1:57Speaker 3: $ 6 billion in annual revenue post-merger. So, initially, interestingly, initially,
- 2:04Speaker 3: Informa shares dipped. So, it's being funded through an equity placement.
- 2:08Speaker 3: And they're also pausing their current share buyback program. So, potentially,
- 2:11Speaker 3: that pulled shares slightly lower as markets opened. They're now
- 2:14Speaker 3: up about 4%. Analysts are saying that even if it
- 2:17Speaker 3: does come at a cost, It's a strong fit. So,
- 2:20Speaker 3: they complement each other. And also, linked to this is
- 2:25Speaker 3: Informa saying that they might separate their publishing units. So,
- 2:27Speaker 3: really focusing on business events with both of those deals. Okay.
- 2:32Speaker 2: And some deals also in focus in the banking sector
- 2:36Speaker 2: and Sabadell.
- 2:38Speaker 3: Yes. So, BPCE, the French banking group, has bought a 7%
- 2:41Speaker 3: stake in Sabadell. That's valued at just over kind of
- 2:47Speaker 3: € 1 billion-ish. making it the second largest shareholder. They will
- 2:52Speaker 3: also have board representation, but they've pledged to keep their
- 2:55Speaker 3: stake below 10%. So, this investment has been called a
- 2:58Speaker 3: friendly investment. The goal is to be collaborative and work together.
- 3:03Speaker 3: Shares of Sabadell are rising on the back of this,
- 3:05Speaker 3: up over about 3%. They're saying that it shows the
- 3:08Speaker 3: strength of themselves as an individual. So, obviously, Sabadell fought
- 3:13Speaker 3: off BBVA last year, a takeover from BBVA. Analysts say
- 3:18Speaker 3: that this move reinforces the investment case for Sabadell going
- 3:24Speaker 3: it alone. A great quote from one analyst saying that
- 3:27Speaker 3: they found a white knight that can defend it against
- 3:29Speaker 3: another bid. So, reducing the M & A speculative appeal.
- 3:35Speaker 1: The Stock Movers Report from Bloomberg Radio. Check back with
- 3:39Speaker 1: us throughout the day for the latest roundup of companies
- 3:41Speaker 1: making news on Wall Street. And for the latest market-moving headlines,
- 3:46Speaker 1: listen to Bloomberg Radio Live. Catch us on YouTube, Bloomberg.com,
- 3:50Speaker 1: and on Apple CarPlay and Android Auto with the Bloomberg
- 3:53Speaker 1: Business app.